Luvox
| Product dosage: 100mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $3.13 | $94.00 (0%) | 🛒 Add to cart |
| 60 | $2.27 | $188.00 $136.00 (28%) | 🛒 Add to cart |
| 90 | $1.97 | $282.00 $177.00 (37%) | 🛒 Add to cart |
| 120 | $1.83 | $376.00 $220.00 (41%) | 🛒 Add to cart |
| 180 | $1.68 | $564.00 $303.00 (46%) | 🛒 Add to cart |
| 270 | $1.58
Best per pill | $846.00 $427.00 (50%) | 🛒 Add to cart |
| Product dosage: 50mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.80 | $54.00 (0%) | 🛒 Add to cart |
| 60 | $1.37 | $108.00 $82.00 (24%) | 🛒 Add to cart |
| 90 | $1.22 | $162.00 $110.00 (32%) | 🛒 Add to cart |
| 120 | $1.15 | $216.00 $138.00 (36%) | 🛒 Add to cart |
| 180 | $1.08 | $324.00 $194.00 (40%) | 🛒 Add to cart |
| 270 | $1.03 | $486.00 $278.00 (43%) | 🛒 Add to cart |
| 360 | $1.00
Best per pill | $648.00 $360.00 (44%) | 🛒 Add to cart |
Synonyms | |||
More info:
Pletal: Advanced Peripheral Artery Disease Symptom Relief
Pletal (cilostazol) is a quinolinone-derived phosphodiesterase III inhibitor specifically indicated for the reduction of symptoms of intermittent claudication, a manifestation of peripheral artery disease. This vasodilatory and antiplatelet agent works through dual mechanisms of action to improve microcirculatory blood flow and increase pain-free walking distance. It represents a cornerstone of pharmacologic management for patients whose symptoms are not adequately controlled by exercise and lifestyle modification alone. Clinical efficacy is well-established through multiple randomized controlled trials demonstrating significant functional improvement.
Tizanidine: Effective Muscle Spasm Relief for Enhanced Mobility
Tizanidine hydrochloride is a centrally acting alpha-2 adrenergic agonist, classified as a short-acting muscle relaxant. It is primarily indicated for the management of spasticity, a condition characterized by increased muscle tone and involuntary muscle spasms, which can significantly impair functional capacity and comfort. This agent works by inhibiting excitatory interneurons within the spinal cord, thereby reducing the release of excitatory neurotransmitters and diminishing tonic stretch reflexes. Its therapeutic profile makes it a valuable option in neurological and musculoskeletal rehabilitation protocols, offering patients a pathway to improved movement and reduced discomfort.
Zanaflex: Targeted Muscle Spasm Relief with Tizanidine
Zanaflex (tizanidine hydrochloride) is a short-acting muscle relaxant indicated for the management of increased muscle tone associated with spasticity. It functions as a central alpha-2-adrenergic agonist, effectively reducing the frequency and amplitude of muscle spasms to improve functional capacity and comfort. This prescription medication is commonly utilized in conditions such as multiple sclerosis, spinal cord injury, and certain neurological disorders where spasticity impairs daily activities or causes discomfort. Proper dosing and medical supervision are essential to maximize therapeutic outcomes while minimizing potential adverse effects.
Actoplus Met: Dual-Action Control for Type 2 Diabetes
Actoplus Met combines two proven antihyperglycemic agents, pioglitazone and metformin, into a single tablet to provide comprehensive glycemic management for adults with type 2 diabetes mellitus. This fixed-dose combination therapy targets two key pathophysiological defects of the disease—insulin resistance and hepatic glucose overproduction—offering a synergistic approach to lower both fasting and postprandial blood glucose levels. By addressing multiple mechanisms simultaneously, it can simplify treatment regimens and improve adherence, which is critical for long-term metabolic control and reducing the risk of diabetes-related complications.
Actos: Advanced Type 2 Diabetes Management with Pioglitazone
Actos (pioglitazone hydrochloride) is a thiazolidinedione-class oral antidiabetic agent indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. By enhancing insulin sensitivity in peripheral tissues, it addresses core pathophysiological defects associated with the disease. This medication is designed for long-term management, helping to stabilize blood glucose levels and potentially reduce the risk of diabetic complications when used as part of a comprehensive treatment plan under medical supervision.
Amaryl: Advanced Glycemic Control for Type 2 Diabetes
Amaryl (glimepiride) is a second-generation sulfonylurea oral antidiabetic agent indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. It functions primarily by stimulating insulin secretion from the pancreatic beta cells. This medication is recognized for its once-daily dosing convenience and its role in comprehensive diabetes management strategies, often used both as monotherapy and in combination with other antihyperglycemic agents when needed.
Baclofen: Effective Muscle Spasticity Relief for Enhanced Mobility
Baclofen is a centrally-acting skeletal muscle relaxant primarily indicated for the management of muscle spasticity. It functions as a gamma-aminobutyric acid (GABA) derivative, specifically targeting GABA-B receptors within the spinal cord to inhibit monosynaptic and polysynaptic reflex transmission. This pharmacological action results in reduced muscle tone and frequency of spasms, offering significant symptomatic relief for patients with neurological conditions. Clinicians value baclofen for its targeted mechanism and well-established efficacy profile in both oral and intrathecal formulations.
Baclosign: Targeted Spasticity Relief with Precision Muscle Relaxation
Baclosign (baclofen) is a centrally acting skeletal muscle relaxant specifically formulated for the management of spasticity resulting from multiple sclerosis, spinal cord injuries, and other neurological diseases. It operates as a gamma-aminobutyric acid (GABA) agonist, primarily exerting its effect at the spinal cord level to inhibit monosynaptic and polysynaptic reflex transmission. This targeted mechanism reduces the frequency and amplitude of muscle spasms, alleviates associated pain, and improves range of motion, thereby facilitating daily activities and therapeutic regimens.
Colospa: Targeted Relief for Irritable Bowel Syndrome Discomfort
Colospa (mebeverine hydrochloride) is an antispasmodic agent specifically formulated for the symptomatic management of Irritable Bowel Syndrome (IBS). It functions as a direct smooth muscle relaxant, acting predominantly on the gastrointestinal tract to alleviate spasmodic pain and cramping without affecting normal gut motility. By targeting the underlying muscle hyperactivity responsible for discomfort, Colospa provides focused relief, helping to restore daily comfort and function for individuals affected by IBS. Its selective action minimizes systemic side effects, making it a well-tolerated option for long-term symptom control.